Mutations in DNMT3A, U2AF1, and EZH2 identify intermediate-risk acute myeloid leukemia patients with poor outcome after CR1
Saygin, Caner, Hirsch, Cassandra, Przychodzen, Bartlomiej, Sekeres, Mikkael A., Hamilton, Betty K., Kalaycio, Matt, Carraway, Hetty E., Gerds, Aaron T., Mukherjee, Sudipto, Nazha, Aziz, Sobecks, RonalVolume:
8
Langue:
english
Journal:
Blood Cancer Journal
DOI:
10.1038/s41408-017-0040-9
Date:
January, 2018
Fichier:
PDF, 1.61 MB
english, 2018